You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Pulmonary hypertension (PH) is increased pressure in the pulmonary arteries, which carry blood from the heart to the lungs to pick up oxygen. The changes resulting from PH make it difficult for the heart to push blood through the pulmonary arteries, causing the heart to become weak and possibly to develop failure. Understanding the causes and treatment of PH can help heart failure specialists prevent heart failure due to PH.
In ST segment elevation myocardial infarction (STEMI), the coronary artery is completely blocked by a blood clot. It is the most serious type of heart attack. The best treatment for STEMI patients is to have the blocked artery opened by balloon inflation within 90 minutes of arriving at a hospital. The 90-minute window is called "door-to-balloon time. The shorter the door-to-balloon time, the greater the chance of survival. Treatment of this life-threatening illness is reviewed in this issue.
This book constitutes the refereed proceedings of the 17th Conference on Artificial Intelligence in Medicine, AIME 2019, held in Poznan, Poland, in June 2019. The 22 revised full and 31 short papers presented were carefully reviewed and selected from 134 submissions. The papers are organized in the following topical sections: deep learning; simulation; knowledge representation; probabilistic models; behavior monitoring; clustering, natural language processing, and decision support; feature selection; image processing; general machine learning; and unsupervised learning.
This book provides the framework for a singular reference in the field of pulmonary hypertension. Pulmonary vascular disease is a complex and heterogeneous condition characterized by remodeling of distal pulmonary arterioles that increases pulmonary vascular resistance to affect cardiopulmonary hemodynamic and right ventricular function adversely, resulting in a clinical syndrome of diminished exercise tolerance, shortness of breath, and heart failure-associated morbidity and mortality. Owing to the availability of novel pulmonary circulation-selective pharmacotherapies over the previous decade, the number of pulmonary hypertension patients eligible for treatment has increased substantially....
Consumers today are increasingly more likely to treat their illnesses with OTC drug products without seeking advice from a physician. And advice about OTC medication is frequently sought from a pharmacist prior to a doctor's visit. APhA's Handbook of Nonprescription Drugs, 12th Edition, is the essential resource to enhance your ability to provide consumers with OTC product and related information.Now in one easy-to-use volume, pharmacy students, practitioners, and other health professionals will find the most comprehensive discussion of nonprescriptiontreatment ever presented. Completely updated, the Handbook of Nonprescription Drugs, 12th Edition, focuses on an integrated therapeutic approa...
In this issue of Medical Clinics of North America, guest editor Dr. Douglas Paauw brings his considerable expertise to the topic of Newer Outpatient Therapies and Treatments. Top experts provide insights into recent pharmacologic treatments, review new uses for old drugs, discuss new technologies used in the outpatient setting, and address complementary/alternative options with strong evidence. - Contains 12 relevant, practice-oriented topics including therapy for hyperlipidemia; newer diabetes therapies and technologies; update on antiviral therapies; update in treatments for men's health; newer therapies for psychiatric disease; and more. - Provides in-depth clinical reviews on newer outpatient therapies and treatments, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.